Literature DB >> 3337743

Mechanisms of cross-resistance to methotrexate and 5-fluorouracil in an A2780 human ovarian carcinoma cell subline resistant to cisplatin.

E M Newman1, Y Lu, M Kashani-Sabet, V Kesavan, K J Scanlon.   

Abstract

Some properties of the human ovarian carcinoma line A2780 and a subline three times more resistant than the parent line to cisplatin are compared in this report. The rates of uptake and release of cisplatin were similar in the two cell lines. Resistance to cisplatin was associated with: (a) cross-resistance to 5-fluorouracil and methotrexate; (b) a 2.5-fold increase in thymidylate synthase, as measured by both enzyme activity and the capacity to complex 5-fluorodeoxyuridylate; and (c) an increase in the intracellular pools of 5,10-methylenetetrahydrofolate and tetrahydrofolate. These data suggest that cross-resistance to 5-fluorouracil and methotrexate in A2780 cells may be a consequence of increases in their respective target enzymes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3337743     DOI: 10.1016/0006-2952(88)90212-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Molecular profiling of a case of advanced pancreatic cancer identifies an active and tolerable combination of targeted therapy with backbone chemotherapy.

Authors:  Benny Johnson; Ari Vanderwalde; Nader Javadi; Rebecca Feldman; Sandeep Bobby Reddy
Journal:  J Gastrointest Oncol       Date:  2016-04

2.  Identification and characterization of a 66-68-kDa protein as a methotrexate-binding protein in murine leukemia L1210 cells.

Authors:  Tuoen Liu; Allison Dean; Saint Ashwini; Peter P Sheridan; Alok Bhushan; James C K Lai; Shousong Cao; Christopher K Daniels
Journal:  Cell Stress Chaperones       Date:  2012-10-23       Impact factor: 3.667

3.  Relationship between folate-binding protein expression and cisplatin sensitivity in ovarian carcinoma cell lines.

Authors:  F Ottone; S Miotti; C Bottini; M Bagnoli; P Perego; M I Colnaghi; S Ménard
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Dynamic modulation of thymidylate synthase gene expression and fluorouracil sensitivity in human colorectal cancer cells.

Authors:  Kentaro Wakasa; Rumi Kawabata; Seiki Nakao; Hiroyoshi Hattori; Kenichi Taguchi; Junji Uchida; Takeharu Yamanaka; Yoshihiko Maehara; Masakazu Fukushima; Shinya Oda
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

5.  Characterization of acquired resistance to cis-diamminedichloroplatinum(II) in mouse leukemia cell lines.

Authors:  T Tashiro; Y Sato
Journal:  Jpn J Cancer Res       Date:  1992-02

6.  Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting.

Authors:  Gaetano Marverti; Chiara Marraccini; Andrea Martello; Domenico D'Arca; Salvatore Pacifico; Remo Guerrini; Francesca Spyrakis; Gaia Gozzi; Angela Lauriola; Matteo Santucci; Giuseppe Cannazza; Lorenzo Tagliazucchi; Addolorata Stefania Cazzato; Lorena Losi; Stefania Ferrari; Glauco Ponterini; Maria P Costi
Journal:  J Med Chem       Date:  2021-03-12       Impact factor: 7.446

7.  Mechanisms of collateral sensitivity to fluorouracil of a cis-diamminedichloroplatinum(II)-resistant human non-small lung cancer cell line.

Authors:  Y Sugimoto; Y Ohe; K Nishio; T Ohmori; T Morikage; Y Fujiwara; N Saijo
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

8.  Characterisation of high-level cisplatin-resistant cell lines established from a human hepatoma cell line and human KB adenocarcinoma cells: cross-resistance and protein changes.

Authors:  D W Shen; S Akiyama; P Schoenlein; I Pastan; M M Gottesman
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.